The key objective of c-ART is to suppress viral replication and to induce the production of sufficient numbers of CD4+ T cells to prevent AIDS-defining (CD4+ T-cell counts below 200 cells/mm3), and non-AIDS-defining (CD4+ T-cell counts below 500 cells/mm3) severe events [1]. The gene discussed is CD4; the disease is AIDS.